Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
PLX	PROTALIX BIOTHERAPEUTICS INC	$222.39M	8.80%	3.70%	10.91%	17.40%	0.70	2.35	54.50%	5.50%	9.77%
AUPH	AURINIA PHARMACEUTICALS INC	$1.12B	1.50%	1.10%	2.71%	2.60%	0.46	4.57	88.00%	2.40%	5.22%
CPRX	CATALYST PHARMACEUTICALS INC	$2.85B	25.60%	22.00%	29.60%	330.80%	0.17	5.17	86.00%	33.30%	43.98%
RIGL	RIGEL PHARMACEUTICALS INC	$344.40M	-95.90%	12.50%	26.11%	39.20%	48.87	2.13	89.60%	9.80%	14.66%
NAGE	NIAGEN BIOSCIENCE INC	$573.80M	24.40%	14.70%	17.59%	94.00%	0.48	3.57	61.80%	8.60%	8.89%
BMRN	BIOMARIN PHARMACEUTICAL INC	$12.08B	8.00%	6.10%	8.69%	9.90%	0.24	5.33	79.70%	15.00%	19.43%
EXEL	EXELIXIS INC	$10.48B	23.80%	18.20%	26.79%	28.50%	0.31	3.64	96.50%	24.00%	31.43%
JAZZ	JAZZ PHARMACEUTICALS PLC	$6.73B	14.20%	4.80%	6.44%	9.10%	1.93	4.46	89.00%	13.80%	17.37%
TECH	BIO-TECHNE CORP	$7.94B	7.60%	5.80%	8.03%	14.90%	0.29	3.94	65.60%	13.20%	16.85%
XERS	XERIS BIOPHARMA HOLDINGS INC	$663.48M	N/A	-16.70%	-11.96%	-8.20%	-11.91	1.67	81.90%	-27.00%	-13.11%
CRMD	CORMEDIX INC	$593.15M	-29.00%	-22.30%	-22.69%	-74.10%	0.40	3.39	92.70%	-41.20%	-44.37%
CSBR	CHAMPIONS ONCOLOGY INC	$109.23M	656.70%	24.00%	59.51%	60.30%	4.60	0.99	51.60%	11.00%	10.92%
HALO	HALOZYME THERAPEUTICS INC	$7.45B	138.40%	22.20%	29.89%	24.20%	4.67	7.80	84.30%	43.70%	56.65%
FOLD	AMICUS THERAPEUTICS INC	$2.21B	-35.30%	-7.40%	3.28%	3.40%	3.05	3.39	90.00%	-10.60%	3.95%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$1.73B	-77.20%	-32.80%	-41.89%	-28.50%	1.22	4.15	90.30%	-71.30%	-57.10%
GMAB	GENMAB A	$13.63B	23.80%	19.50%	27.51%	64.30%	0.25	5.25	95.40%	36.40%	51.76%
HRTX	HERON THERAPEUTICS INC	$350.36M	N/A	-6.10%	-7.83%	-3.80%	-7.93	2.29	73.20%	-9.40%	-7.69%
UTHR	UNITED THERAPEUTICS CORP	$13.09B	20.30%	17.30%	23.87%	31.80%	0.14	5.25	89.20%	41.50%	54.98%
INCY	INCYTE CORP	$11.45B	0.90%	0.60%	8.39%	15.80%	0.58	1.97	92.60%	0.80%	7.52%
NVO	NOVO NORDISK A S	$277.19B	85.00%	26.40%	51.23%	87.20%	2.25	0.74	84.70%	34.80%	43.80%
THTX	THERATECHNOLOGIES INC	$127.36M	N/A	-5.90%	64.55%	36.10%	-3.31	1.08	79.00%	-4.20%	15.51%
PBYI	PUMA BIOTECHNOLOGY INC	$148.83M	46.10%	14.20%	31.18%	46.50%	1.32	1.54	72.10%	13.10%	15.86%
VRTX	VERTEX PHARMACEUTICALS INC	$126.81B	-3.30%	-2.40%	1.47%	2.30%	0.37	2.69	86.10%	-4.90%	2.53%
KURA	KURA ONCOLOGY INC	$519.25M	-38.50%	-30.20%	-25.00%	-37.20%	0.84	9.46	100.00%	-322.90%	-316.14%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$1.70B	25.20%	16.00%	25.40%	47.70%	0.52	3.31	78.10%	20.40%	29.28%
MNKD	MANNKIND CORP	$1.44B	-14.80%	6.20%	21.95%	9.90%	-6.00	3.28	73.20%	9.70%	23.99%
BCRX	BIOCRYST PHARMACEUTICALS INC	$1.75B	N/A	-18.50%	3.50%	1.10%	-2.03	2.63	97.20%	-19.70%	2.57%
MDXG	MIMEDX GROUP INC	$1.02B	24.30%	17.70%	26.90%	54.60%	0.37	4.21	82.80%	12.20%	16.83%
FENC	FENNEC PHARMACEUTICALS INC	$155.35M	N/A	-0.70%	10.51%	10.60%	-8.65	6.38	93.30%	-0.90%	8.41%
RPRX	ROYALTY PHARMA PLC	$18.56B	8.50%	4.90%	6.39%	4.70%	0.76	1.44	100.00%	37.90%	47.91%
SRPT	SAREPTA THERAPEUTICS INC	$5.86B	19.70%	6.60%	8.07%	7.00%	1.59	4.20	83.20%	12.40%	13.71%
INVA	INNOVIVA INC	$1.14B	3.40%	1.90%	5.60%	5.40%	0.88	2.35	89.80%	6.50%	16.61%
TGTX	TG THERAPEUTICS INC	$6.49B	12.40%	4.80%	10.19%	11.70%	1.60	6.25	88.30%	7.10%	15.08%
LGND	LIGAND PHARMACEUTICALS INC	$2.08B	-0.50%	-0.40%	0.61%	1.20%	0.13	8.93	93.40%	-2.40%	3.32%
ARGX	ARGENX SE	$37.35B	17.40%	15.50%	1.58%	3.00%	0.13	7.29	-5,127.40%	19,159.20%	2,015.73%
GLUE	MONTE ROSA THERAPEUTICS INC	$311.24M	-36.10%	-21.30%	-24.89%	-41.20%	0.97	2.41	100.00%	-96.10%	-92.74%
ACAD	ACADIA PHARMACEUTICALS INC	$2.46B	39.50%	23.00%	32.55%	75.00%	0.62	2.38	91.50%	23.60%	26.94%
TARS	TARSUS PHARMACEUTICALS INC	$1.92B	-46.70%	-31.20%	-36.34%	-52.90%	0.68	4.43	93.00%	-63.20%	-58.87%
ABUS	ARBUTUS BIOPHARMA CORP	$629.97M	-63.40%	-48.00%	-60.11%	-82.80%	0.35	8.15	100.00%	-1,133.00%	-1,130.82%
ARDX	ARDELYX INC	$1.25B	-24.90%	-10.50%	-7.23%	-6.90%	1.52	4.58	84.80%	-11.70%	-7.75%
VCEL	VERICEL CORP	$1.99B	4.00%	2.70%	2.91%	3.10%	0.48	4.23	72.60%	4.40%	4.69%
IVVD	INVIVYD INC	$77.97M	-144.70%	-99.30%	-251.60%	1,816.10%	0.92	1.63	93.60%	-669.40%	-669.42%
STOK	STOKE THERAPEUTICS INC	$527.80M	-42.20%	-33.00%	-43.90%	-158.20%	0.19	5.81	100.00%	-243.40%	-277.99%
ASND	ASCENDIS PHARMA A	$9.96B	N/A	-39.40%	-100.58%	-66.30%	-12.16	1.17	87.80%	-104.00%	-75.13%
REGN	REGENERON PHARMACEUTICALS INC	$65.88B	15.50%	12.10%	14.30%	15.10%	0.29	4.73	86.10%	31.10%	34.05%
ADMA	ADMA BIOLOGICS INC	$5.19B	85.70%	49.20%	32.24%	37.00%	0.40	5.97	51.50%	46.40%	32.75%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$1.55B	-9.90%	-7.90%	-7.53%	-11.00%	0.32	3.30	85.60%	-10.20%	-8.54%
CTMX	CYTOMX THERAPEUTICS INC	$56.87M	-146.80%	21.10%	92.32%	-1,013.20%	-265.33	1.25	100.00%	23.10%	23.24%
KRYS	KRYSTAL BIOTECH INC	$4.84B	10.30%	9.40%	10.00%	18.10%	0.12	7.28	93.10%	30.70%	32.82%
LEGN	LEGEND BIOTECH CORP	$6.29B	-15.80%	-10.10%	-9.80%	-21.80%	0.61	4.62	62.60%	-28.20%	-21.76%
ALNY	ALNYLAM PHARMACEUTICALS INC	$32.57B	N/A	-6.80%	-7.71%	-7.10%	62.20	2.78	85.60%	-12.40%	-10.48%
TLX	TELIX PHARMACEUTICALS LTD	$6.29B	13.90%	5.20%	7.84%	27.90%	1.67	2.78	65.10%	6.40%	11.87%
ONC	BEIGENE LTD	$26.16B	-19.10%	-11.10%	-15.67%	-27.40%	0.78	1.80	84.40%	-16.90%	-15.24%
MGTX	MEIRAGTX HOLDINGS PLC	$528.33M	-161.80%	-51.60%	-64.37%	-65.50%	2.98	2.03	28.50%	-444.10%	-404.22%
XOMA	XOMA ROYALTY CORP	$289.17M	-22.10%	-8.50%	-5.64%	-5.90%	1.70	5.15	100.00%	-67.70%	-39.00%
IMAB	I-MAB	$68.41M	-10.10%	-7.70%	-10.88%	-31.30%	0.06	20.90	N/A	N/A	N/A
VCYT	VERACYTE INC	$2.51B	2.10%	1.90%	2.11%	24.60%	0.11	4.73	66.90%	5.40%	5.78%
ENTA	ENANTA PHARMACEUTICALS INC	$119.04M	-75.50%	-27.30%	-32.38%	-29.80%	2.12	5.47	100.00%	-157.60%	-145.67%
GYRE	GYRE THERAPEUTICS INC	$849.06M	19.90%	9.80%	16.44%	19.90%	0.43	3.32	96.30%	11.40%	16.46%
PVLA	PALVELLA THERAPEUTICS INC	$279.77M	-58.30%	-42.70%	-17.21%	606.80%	0.41	7.33	N/A	N/A	N/A
CORT	CORCEPT THERAPEUTICS INC	$7.57B	22.70%	18.70%	19.36%	27.00%	0.24	3.35	98.40%	20.70%	20.07%
PTCT	PTC THERAPEUTICS INC	$3.91B	N/A	-20.00%	-17.45%	-30.90%	-2.55	2.35	92.90%	-45.00%	-24.31%
GOSS	GOSSAMER BIO INC	$217.68M	-117.80%	-17.40%	-16.32%	-10.20%	9.69	6.89	100.00%	-49.30%	-38.46%
DOMH	DOMINARI HOLDINGS INC	$30.06M	-35.00%	-30.70%	-33.92%	-33.10%	0.18	7.44	100.00%	-81.00%	-81.03%
VNDA	VANDA PHARMACEUTICALS INC	$247.84M	-3.50%	-2.90%	-4.12%	-6.80%	0.22	4.39	94.30%	-9.50%	-11.53%
IBRX	IMMUNITYBIO INC	$2.23B	N/A	-103.90%	-79.04%	-23.20%	-1.78	3.36	100.00%	-2,804.80%	-1,758.13%
WVE	WAVE LIFE SCIENCES LTD	$1.03B	-104.00%	-33.60%	-40.21%	128.60%	0.64	2.89	100.00%	-89.60%	-89.57%
NVAX	NOVAVAX INC	$1.07B	N/A	-11.60%	-38.56%	-218.70%	-3.50	0.98	70.30%	-27.50%	-22.95%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$1.17B	-67.70%	-27.70%	-33.52%	-27.80%	1.66	2.89	59.70%	-89.10%	-82.65%
MIRM	MIRUM PHARMACEUTICALS INC	$2.00B	-38.20%	-13.30%	-13.34%	-20.10%	1.97	3.10	75.80%	-26.10%	-21.55%
TBPH	THERAVANCE BIOPHARMA INC	$482.34M	-29.70%	-15.60%	-13.06%	-12.30%	1.02	5.02	100.00%	-87.60%	-65.34%
MESO	MESOBLAST LTD	$1.36B	-21.30%	-15.60%	-13.73%	-79.50%	0.42	0.96	100.00%	-1,822.80%	-1,405.84%
NTRB	NUTRIBAND INC	$59.08M	-63.00%	-56.10%	-60.26%	-1,972.60%	0.12	4.96	31.60%	-338.70%	-336.65%
VTVT	VTV THERAPEUTICS INC	$70.90M	-114.50%	-40.60%	-55.52%	356.20%	1.97	7.34	100.00%	-1,815.30%	-1,805.51%
ABEO	ABEONA THERAPEUTICS INC	$258.69M	-165.40%	-58.20%	-64.46%	-63.50%	1.47	6.08	N/A	N/A	N/A
APLS	APELLIS PHARMACEUTICALS INC	$2.20B	-79.40%	-22.50%	-22.35%	-22.40%	2.87	4.25	84.90%	-25.30%	-20.01%
NNNN	ANBIO BIOTECHNOLOGY	N/A	N/A	N/A	N/A	N/A	0.03	35.56	N/A	N/A	N/A
ZVRA	ZEVRA THERAPEUTICS INC	$389.63M	-221.30%	-63.40%	-57.47%	-111.00%	3.49	2.53	68.60%	-446.90%	-350.62%
NKTR	NEKTAR THERAPEUTICS	$144.23M	-150.60%	-35.20%	-37.57%	-26.10%	4.00	4.26	68.80%	-120.90%	-92.54%
ANAB	ANAPTYSBIO INC	$634.80M	-272.90%	-32.10%	-33.13%	-45.60%	5.83	9.51	100.00%	-159.10%	-159.10%
KLRS	KALARIS THERAPEUTICS INC	$33.79M	-49.50%	-45.50%	-51.87%	-235.40%	0.05	22.63	N/A	N/A	N/A
CANF	CAN-FITE BIOPHARMA LTD	$10.11M	-134.90%	-82.50%	-111.49%	-259.30%	0.68	4.38	100.00%	-1,169.10%	-1,169.14%
TLSA	TIZIANA LIFE SCIENCES LTD	$140.20M	-140.90%	-91.50%	-305.44%	-509.70%	1.20	1.12	N/A	N/A	N/A
BNTC	BENITEC BIOPHARMA INC	$318.71M	-44.30%	-41.00%	-27.51%	733.40%	0.04	25.48	N/A	N/A	N/A
CLLS	CELLECTIS SA	$42.84M	-29.40%	-9.50%	-6.97%	-9.00%	1.93	1.73	100.00%	-74.70%	-30.78%
TVTX	TRAVERE THERAPEUTICS INC	$1.63B	-1,091.50%	-55.60%	-78.87%	-46.80%	9.06	2.08	96.70%	-137.90%	-133.05%
BNTX	BIONTECH SE	$24.48B	-3.40%	-3.00%	-3.25%	-6.50%	0.16	7.45	80.30%	-24.20%	-23.64%
HURA	TUHURA BIOSCIENCES INC	$179.09M	-348.90%	-240.00%	-119.86%	42,031.10%	0.37	3.68	N/A	N/A	N/A
UPB	UPSTREAM BIO INC	$450.05M	-44.10%	-25.50%	-13.34%	-54.20%	0.03	44.63	100.00%	-3,223.40%	-2,650.04%
AKBA	AKEBIA THERAPEUTICS INC	$562.23M	N/A	-31.80%	-36.65%	-77.90%	-5.49	1.41	60.60%	-43.30%	-31.98%
PULM	PULMATRIX INC	$24.51M	-73.30%	-56.50%	-106.05%	-204.20%	0.11	10.68	100.00%	-122.50%	-122.46%
SPRY	ARS PHARMACEUTICALS INC	$1.35B	3.60%	3.10%	2.53%	3.90%	0.37	14.26	98.90%	9.00%	9.29%
INO	INOVIO PHARMACEUTICALS INC	$68.57M	-128.70%	-88.80%	-137.50%	-150.90%	0.65	2.77	100.00%	-49,254.30%	-49,172.60%
RGNX	REGENXBIO INC	$458.29M	-69.90%	-41.60%	-59.11%	-47.30%	0.80	2.69	59.70%	-272.50%	-257.35%
CAPR	CAPRICOR THERAPEUTICS INC	$595.16M	-66.40%	-46.10%	-27.08%	-94.50%	0.17	7.77	100.00%	-181.70%	-181.71%
MRUS	MERUS NV	$3.01B	-35.20%	-28.50%	-34.21%	-79.70%	0.21	6.54	100.00%	-595.90%	-658.58%
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$2.29B	-1,337.40%	-15.90%	-22.94%	-16.90%	8.87	1.26	97.00%	-41.30%	-33.71%
IKT	INHIBIKASE THERAPEUTICS INC	$156.86M	-103.60%	-89.60%	-29.01%	-246.70%	0.04	26.37	N/A	N/A	N/A
MDGL	MADRIGAL PHARMACEUTICALS INC	$7.22B	-57.50%	-43.40%	-51.69%	-66.80%	0.38	6.10	96.50%	-258.60%	-250.49%
MREO	MEREO BIOPHARMA GROUP PLC	$397.50M	-67.80%	-54.50%	-69.60%	10,076.90%	0.25	5.40	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Apr 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: C.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 23, which is -1 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates PLX as a "A".

PLX passed 7 out of 33 due diligence checks and has weak fundamentals. Protalix Biotherapeutics has seen its stock return 141.53% over the past year, overperforming other biotech stocks by 220 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 426.32% from Protalix Biotherapeutics's current stock price of $2.85.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 57, which is 33 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 67.97% over the past year, overperforming other biotech stocks by 146 percentage points.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: B.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 76, which is 52 points higher than the biotech industry average of 24.

CPRX passed 25 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 59.74% over the past year, overperforming other biotech stocks by 138 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $33.20, an upside of 41.58% from Catalyst Pharmaceuticals's current stock price of $23.45.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 60% have issued a Strong Buy rating, 40% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.68%, which is 5 percentage points higher than the biotech industry average of 1.9%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.6%, which is 1 percentage points higher than the biotech industry average of 1.9%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.34%, which is -1 percentage points lower than the biotech industry average of 1.9%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.65% in the last day, and up 6% over the last week. Intensity Therapeutics was the among the top losers in the biotechnology industry, dropping -37.11% yesterday.

Intensity Therapeutics shares are trading lower after the company announced a $2.35 million public offering.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 2.35% in the past year. It has overperformed other stocks in the biotech industry by 80 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -38.52% in the past year. It has overperformed other stocks in the biotech industry by 40 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 3.14% in the past year. It has overperformed other stocks in the biotech industry by 81 percentage points.

Are biotech stocks a good buy now?

55.47% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 108.65% over the next year.

1.53% of biotech stocks have a Zen Rating of A (Strong Buy), 5.03% of biotech stocks are rated B (Buy), 41.79% are rated C (Hold), 35.67% are rated D (Sell), and 15.97% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -157.91x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.